PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.05%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.70%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-30.38%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-24.93%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-19.88%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-19.88%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-19.88%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3391.T is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.62%
10Y revenue/share CAGR under 50% of 3391.T's 178.41%. Michael Burry would suspect a lasting competitive disadvantage.
50.86%
5Y revenue/share CAGR at 75-90% of 3391.T's 57.97%. Bill Ackman would encourage strategies to match competitor’s pace.
25.47%
3Y revenue/share CAGR 1.25-1.5x 3391.T's 17.63%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.16%
Below 50% of 3391.T's 144.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
22.93%
Positive 5Y CAGR while 3391.T is negative. John Neff might view this as a strong mid-term relative advantage.
21.41%
Positive short-term CAGR while 3391.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
173.04%
10Y equity/share CAGR at 75-90% of 3391.T's 209.70%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
113.90%
5Y equity/share CAGR above 1.5x 3391.T's 61.38%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
53.95%
3Y equity/share CAGR above 1.5x 3391.T's 30.69%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
122.22%
Below 50% of 3391.T's 345.33%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
128.57%
5Y dividend/share CAGR above 1.5x 3391.T's 54.63%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
77.78%
3Y dividend/share CAGR above 1.5x 3391.T's 14.38%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
49.38%
Our AR growth while 3391.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.80%
Inventory growth well above 3391.T's 1.95%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.73%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.86%
1.25-1.5x 3391.T's 2.40%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-7.13%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.19%
SG&A declining or stable vs. 3391.T's 2.90%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.